E:\marcusevansassets\Doc\Events\ Global Financial Markets Intelligence conferences | Biotechnology for the Non-Biotechnologists

Global Financial Markets Intelligence

Global Financial Markets Intelligence

Biotechnology for the Non-Biotechnologists

Understand the Basic Theory, Principles, Techniques, and Potential of Biotechnology

28-29 Apr 2020
NBC Tower | Chicago, IL, United States of America

Why You Should Attend

Biotechnology for the Non-Biotechnologists

This two-day Program will provide a basic understanding of the various elements of biotechnology drug development. You will learn the typical sequence of steps in the development process from discovery to approval, how to choose a CMO, the regulatory requirements for biotechnology drug development, an overview of mammalian cell manufacturing processes, and average costs for those items.

Key Topics

  • The History of Biologics
  • The Current Types of Processes
  • An Overview of Cell Lines
  • Developming the Manufacturing Process
  • What are you entitled to from the CMO?
  • Previous Attendees Include

    Pfizer Learning Center
    Isis Pharmaceuticals Inc.
    Merck & Company Inc.
    Nerugen Corporation
    Purdue Pharmaceuticals
    Ranbaxy Pharmaceuticals Inc.
    Amgen Incorporated
    Celegene Corporation
    Forest Pharmaceuticals Inc.

    Why Choose GFMI marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Practical Insights From

    Arvilla Trag
    As a Consultant for BioProcess Technology Consultants, Arvilla Trag has accumulated 27 years of experience in biotechnology, new drug development, QA/RA manufacturing compliance, and submission preparation. Serving as the President of Midwest Consulting Services, Inc. from 1997 to 2016, Arvilla has prepared dozens of INDs, and several Module 3 and 2.3 sections for BLAs. In addition to detailed submissions preparation. She brings a broad range of biotech product type experience, having participated in over two dozen development programs of several different biotech product,s including monoclonal antibodies, vaccines, small molecules, and combination products.

    Click Here For Full Agenda

    Voice of Our Customers
    • "Great intimate environment for sharing across industries and getting to the essence of challenges and solutions." - Johnson & Johnson Healthcare
    • "marcus evans provided a varied program with both access to subject matter experts and best practices in a interactive setting." - North Shore Long Island Jewish Health System
    • "I have a lot of notes and ideas. My brain is bursting!" - Philips Healthcare Informatics
    Join the Discussion

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Emily Jones

    marcusevans, The NBC Tower
    455 N. Cityfront Plaza Dr.
    Chicago, IL 60611

    312.540.3000 x6714
    Fax: 312.894.6304
    Email: emilyj@marcusevansch.com